Integrated Medical Cannabis Consultations in a Palliative Care Program: Policies, Procedures, and Progress after Six Years of Practice

J Palliat Med. 2022 May;25(5):802-806. doi: 10.1089/jpm.2021.0577. Epub 2022 Mar 18.

Abstract

Introduction: Our academic ambulatory palliative care program has counseled, monitored, and certified patients for cannabis as part of routine palliative care practice for six years. Objective: We describe the population certified for cannabis and policies, procedures, and medicolegal challenges in our palliative care clinic. Methods: We performed a retrospective review of patients, qualifying diagnoses for cannabis certification, reasons for referral, and number of annual certifications. Results: Between 2015 and 2021, we certified 1711 patients for cannabis. The most common indications were cancer (64%), pain (24%), and neuropathy (9%). Other three months in 2021, 28% of new referrals to our practice were certified for cannabis and 15% of patients were referred explicitly for cannabis certification. Conclusion: Despite legal and practical challenges to implementing a medical cannabis program, our palliative care program has fully integrated cannabis as part of our standard outpatient clinical practice.

Keywords: medical cannabis; outpatient palliative care; pain management; shared decision making; symptom management.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics
  • Hallucinogens*
  • Hospice and Palliative Care Nursing*
  • Humans
  • Medical Marijuana* / therapeutic use
  • Palliative Care
  • Policy
  • Referral and Consultation

Substances

  • Analgesics
  • Hallucinogens
  • Medical Marijuana